Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology

Campi, Riccardo; Brookman-May, Sabine; Subiela Henriquez, Jose; AKDOĞAN, BÜLENT; Brausi, Maurizio; Klatte, Tobias; Langenhuijsen, Johan; Linares-Espinos, Estefania; Marszalek, Martin; Roupret, Morgan; Stief, Christian; Volpe, Alessandro; Minervini, Andrea; Rodriguez-Faba, Oscar

doi:10.1016/j.euf.2018.04.001

Impact of Metabolic Diseases, Drugs, and Dietary Factors on Prostate Cancer Risk, Recurrence, and Survival: A Systematic Review by the European Association of Urology Section of Oncological Urology

Campi R., Brookman-May S. D., Subiela Henriquez J. D., AKDOĞAN B., Brausi M., Klatte T., ...Daha Fazla

EUROPEAN UROLOGY FOCUS, cilt.5, sa.6, ss.1029-1057, 2019 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Derleme
Cilt numarası: 5 Sayı: 6
Basım Tarihi: 2019
Doi Numarası: 10.1016/j.euf.2018.04.001
Dergi Adı: EUROPEAN UROLOGY FOCUS
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.1029-1057
Hacettepe Üniversitesi Adresli: Evet

Özet

Context: To date, established risk factors for prostate cancer (PCa) are limited to age, race, family history, and certain genetic polymorphisms. Despite great research efforts, available evidence on potentially modifiable risk factors is conflicting. Moreover, most studies on PCa risk factors did not consider the impact of prostate-specific antigen (PSA) testing on PCa diagnosis.